Medications for Sleep Initiation And Maintenance Disorders

72 results

  • Ambien (zolpidem tartrate)

    (zolpidem tartrate)
    Cosette Pharmaceuticals, Inc.
    Usage: AMBIEN CR (zolpidem tartrate extended-release tablets) is indicated for the short-term treatment of insomnia, specifically for difficulties with sleep onset and maintenance. Efficacy was established in clinical trials lasting up to 24 weeks.

  • Ambien (zolpidem tartrate)

    (zolpidem tartrate)
    Cosette Pharmaceuticals, Inc.
    Usage: AMBIEN (zolpidem tartrate) is indicated for the short-term treatment of insomnia, specifically to help with difficulties in initiating sleep. It has demonstrated effectiveness in reducing sleep latency for up to 35 days based on clinical studies.

  • Doxepin (doxepin)

    (doxepin)
    Zydus Pharmaceuticals USA Inc.
    Usage: Doxepin Tablets are indicated for treating insomnia, specifically for individuals who have difficulty maintaining sleep. Efficacy has been supported by clinical trials lasting up to three months.

  • Doxepin hydrochloride (doxepin hydrochloride)

    (Doxepin hydrochloride)
    Novadoz Pharmaceuticals LLC
    Usage: Doxepin tablets are indicated for treating insomnia with difficulty in sleep maintenance, supported by clinical trials lasting up to 3 months.

  • Doxepin hydrochloride (doxepin hydrochloride)

    (Doxepin Hydrochloride)
    Mylan Pharmaceuticals Inc.
    Usage: Doxepin hydrochloride tablets are indicated for treating insomnia, specifically for difficulties with maintaining sleep. Efficacy was supported by clinical trials lasting up to three months.

  • Doxepin hydrochloride (doxepin hydrochloride)

    (Doxepin hydrochloride)
    REMEDYREPACK INC.
    Usage: Doxepin tablets are indicated for treating insomnia, specifically for patients experiencing difficulty with sleep maintenance. Efficacy has been supported by clinical trials lasting up to 3 months.

  • Estazolam (estazolam)

    (Estazolam)
    Actavis Pharma, Inc.
    Usage: Estazolam is indicated for the short-term management of insomnia, particularly for difficulties in falling asleep, nocturnal awakenings, and early morning awakenings. It is effective in improving sleep induction and maintenance, with evidence supporting its use for up to 12 weeks. Prolonged use is generally not recommended.

  • Eszopiclone (eszopiclone)

    (ESZOPICLONE)
    Bionpharma Inc.
    Usage: Eszopiclone tablets are indicated for the treatment of insomnia. They effectively decrease sleep latency and improve sleep maintenance, as shown in clinical trials lasting up to 6 months.

  • Eszopiclone (eszopiclone)

    (Eszopiclone)
    Advanced Rx Pharmacy of Tennessee, LLC
    Usage: Eszopiclone tablets are indicated for the treatment of insomnia, effectively decreasing sleep latency and improving sleep maintenance based on clinical trials lasting up to 6 months. Efficacy assessments were conducted at multiple points, including 4 weeks for adults and at 2 weeks for the elderly.